-+ 0.00%
-+ 0.00%
-+ 0.00%

Watching Telomir Pharmaceuticals; Zacks Small-Cap Research Reaffirms $15.50 Price Valuation

Benzinga·09/09/2025 19:12:04
Listen to the news